Abstract: A wrist temperature rhythm acquisition apparatus and method, a core temperature rhythm acquisition apparatus and method, and a wearable device are provided. The wrist temperature rhythm acquisition apparatus includes a data acquirer configured to acquire wrist temperature data of a user and external environment temperature data; and a processor configured to estimate wrist temperature rhythm data in which an influence of an external environment temperature is corrected, based on the acquired wrist temperature data and the acquired external environment temperature data.

Abstract: A wearable measurement apparatus capable of measuring a biometric signal is provided. The wearable measurement apparatus includes a main body, and a main-body elastic part disposed on a bottom surface of the main body, and configured to elastically support the main body against a body part of a user. The wearable measurement apparatus further includes a biometric signal sensor disposed apart from the main-body elastic part, and configured to detect a biometric signal from the body part, and a sensor elastic part interposed between the main body and the biometric signal sensor, and configured to form a step difference between a bottom surface of the biometric signal sensor and a bottom surface of the main-body elastic part, and elastically support the biometric signal sensor against the main body.

Abstract: The present invention relates to a biaryl derivative expressed by the chemical formula 1, a method for producing the biaryl derivative, a pharmaceutical composition comprising same, and use of same, the biaryl derivative expressed by the chemical formula 1, as a GPR120 agonist, promoting GLP-1 generation in the gastro-intestinal tract, reducing insulin resistance in the liver, muscles and the like from anti-inflammatory activity in the macrophage, pancreatic cells and the like, and allowing effective use in prevention or treatment of inflammation or metabolic diseases such as diabetes, complications from diabetes, obesity, non-alcoholic fatty liver disease, fatty liver disease, and osteoporosis.

Abstract: An apparatus for extracting a cardiovascular characteristic is provided. The apparatus may include: a first sensor configured to measure a vibration signal generated by a pulse wave of a subject; a second sensor configured to measure a pulse wave signal of the subject; a processor configured to perform an operation related to a cardiovascular characteristic on the basis of the measured vibration signal and pulse wave signal; and a main body in which the first sensor, the second sensor, and the processor are mounted.

Abstract: An electrode, a biosignal detecting device and a method of measuring a biosignal are provided. The electrode includes an ion conductive member configured to be attached to a body surface, a nonconductive member including a through hole and disposed on the ion conductive member, a conductive member disposed on the nonconductive member, and a nonpolarizable conductive member configured to electrically couple the ion conductive member to the conductive member.

Abstract: Provided is a technology for measuring a user's blood pressure by using light sources, in which the blood pressure measuring apparatus includes: a light emitter configured to emit one or more lights having different penetration characteristics toward a user; a light receiver configured to receive the lights that have penetrated through the user, and acquire photo-plethysmography (PPG) signals from the received lights; and a blood pressure measurer configured to measure a phase difference between the acquired PPG signals, and measure a blood pressure based on the measured phase difference.

Abstract: The present invention relates to thioaryl derivatives of Formula 1 as defined in the specification, a method for preparing the same, a pharmaceutical composition comprising the same and use thereof. The thioaryl derivatives of Formula 1 according to the present invention promote GLP-1 formation in the gastrointestinal tract and improve insulin resistance in macrophages, pancreas cells, etc. due to anti-inflammatory action, and can accordingly be effectively used for preventing or treating diabetes, complications of diabetes, inflammation, obesity, non-alcoholic fatty liver, steatohepatitis or osteoporosis.

Abstract: The present invention relates to biaryl derivatives of Formula 1, a method for preparing the same, a pharmaceutical composition comprising the same and use thereof. The biaryl derivatives of Formula 1 according to the present invention promote GLP-1 formation in the gastrointestinal tract and improve insulin resistance in the liver or in muscle due to anti-inflammatory action in macrophages, lipocytes, etc., and can accordingly be effectively used for preventing or treating diabetes, complications of diabetes, obesity, non-alcoholic fatty liver, steatohepatitis, osteoporosis or inflammation.

Abstract: The present invention relates to thioaryl derivatives of Formula 1 as defined in the specification, a method for preparing the same, a pharmaceutical composition comprising the same and use thereof. The thioaryl derivatives of Formula 1 according to the present invention promote GLP-1 formation in the gastrointestinal tract and improve insulin resistance in macrophages, pancreas cells, etc. due to anti-inflammatory action, and can accordingly be effectively used for preventing or treating diabetes, complications of diabetes, inflammation, obesity, non-alcoholic fatty liver, steatohepatitis or osteoporosis.

Abstract: An electrode, a biosignal detecting device and a method of measuring a biosignal are provided. The electrode includes an ion conductive member configured to be attached to a body surface, a nonconductive member including a through hole and disposed on the ion conductive member, a conductive member disposed on the nonconductive member, and a nonpolarizable conductive member configured to electrically couple the ion conductive member to the conductive member.

Abstract: Provided are a photoplethysmographic measurement apparatus, a photoplethysmographic measurement method, and an apparatus for measuring a biosignal. The photoplethysmographic measurement apparatus includes a probe, a light emitter comprising a nonelectrical light source and disposed at one end of the probe, the light emitter configured to illuminate a measurement part, and a light receiver disposed at another end of the probe and configured to detect light reflected or transmitted by the illuminated measurement part.

Abstract: A bio-electrode for measuring a biosignal of a user and an apparatus and method for processing a biosiginal including the bio-electrode are disclosed. The bio-electrode may include a first electrode to measure a biosignal of a user, an initial second electrode to measure a motion signal corresponding to a motion artifact included in the biosignal, and a support member to support the first electrode and the second electrode in proximity to the user. The biosignal may be processed to improve the quality of the biosignal by using the motion signal.

Abstract: A bio-electrode device, bio-measurement device, and a method for implementing a bio-electrode device are provided. Information, such as usage information or patient information, may be maintained in a bio-electrode device, and the information maintained may be transferred to a bio-measurement device in response to the bio-electrode device being coupled to the bio-measurement device.

Abstract: Provided is a sensor platform and a method of preparing the same. The sensor platform may include a hydrogel sheet comprising a net structure; an electrolyte applied to the net structure; and a plurality of electrodes disposed on the hydrogel sheet.

Abstract: An antenna and a method of manufacturing the antenna are provided. The antenna may include an antenna surface, a ground plane, and an air layer comprising a porous structure.